Tristel plc (AIM: TSTL)
London
· Delayed Price · Currency is GBP · Price in GBX
437.55
-2.45 (-0.56%)
Nov 19, 2024, 9:00 AM GMT+1
Tristel Company Description
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally.
The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other.
It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.
Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.
Tristel plc
Country | United Kingdom |
Founded | 1993 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
Employees | 250 |
CEO | Matthew Sassone |
Contact Details
Address: Lynx Business Park Snailwell, CB8 7NY United Kingdom | |
Phone | 44 16 3872 1500 |
Website | tristel.com |
Stock Details
Ticker Symbol | TSTL |
Exchange | London Stock Exchange AIM |
Fiscal Year | July - June |
Reporting Currency | GBP |
ISIN Number | GB00B07RVT99 |
SIC Code | 2840 |
Key Executives
Name | Position |
---|---|
Matthew Sassone | Chief Executive Officer |
Elizabeth Dixon | Chief Financial Officer |